Canada’s health system
is nominally nationalized, but in a way that leaves large gaps in coverage–for long term, in home, specialty care and prescriptions–as well as variable by province. According to this article in HIT Consultant
, VC funding is also thin on the ground, which leads to a short-term outlook. Local governments are stepping into the gap with innovation funding (similar to the Partnership for NYC) and the national government has eased restrictions on foreign investment. EHRs haven’t been a priority (skipping the troubles experienced in the US) which leaves digital health–telehealth, telemedicine and diagnostic apps–to enjoy the available talent and funding. This Editor doubts that any of the 20 profiled here will be familiar names other than possibly InterAxon
which we noted at last year’s NYeC Digital Health Conference
, and many tread the familiar ground of genomics, social sharing of medical images, and gamification for behavior change, but there are three unique companies in the neurological area in nerve stimulation (MyndTec
), nerve disorder diagnostics imaging (NerveVision
) and pharma (Oxalys.
) We salute the Royal Canadian Air Force with their WW2 roundel on the anniversary of the Allied invasion of Sicily, July – August 1943